Wed. 8 May 2024, 1:58am ET
Benzinga
Earnings, Earnings Misses, News
Pharming (NASDAQ:PHAR) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.01 by 290 percent. This is unchanged from the same period last year. The company reported quarterly sales of $55.586 million which missed the analyst consensus estimate of $68.425 million by 18.76 percent. This is a 30.66 percent increase over sales of $42.541 million the same period last year.